We take a look at the company's story, from its creation as a merger of two equals, to its recent major restructuring and its drives in cutting-edge oncology and COVID-19. In 1998, Europe’s ...

Canada also encouraged industry's R&D with generous tax credits. Multinational pharmaceutical ... Novartis, Pfizer, Roche, Sanofi Aventis and Sanofi Pasteur. He has been closely involved in ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Germany’s Bayer saw its shares tumble almost 11% to 21.76 euros this morning, as it reported level third-quarter 2024 sales ...

Givastomig data presented at ESMO 2024 and SITC 2024 highlights encouraging monotherapy data On track to dose first patient in randomized Phase 2 study of uliledlimab ...

Net loss from continuing operations was $ (20.5) million and $ (38.9) million for the three and nine months ended September 30, 2024, respectively, compared to $ (8.2) million and $ (45.3) million for ...

In terms of industry tailwinds, Trump could lessen pressure from the Federal Trade Commission on mergers and acquisitions, ...

Ontada®, a McKesson business and leader in community oncology real-world data, clinical education, and point of care technologies, has announced a strategic collaboration with Datavant, a health data ...

If you’re on the fence about investing in Sanofi SA (ADR) or Novartis AG (ADR ... neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular ...

Lea Uradu, J.D. is a Maryland State Registered Tax Preparer, State Certified Notary Public, Certified VITA Tax Preparer, IRS Annual Filing Season Program Participant, and Tax Writer ...